Christina Smolke, PhD, co-founder and CEO of Antheia, describes how biomanufacturing can provide sustainable, high-quality APIs and KSMs, and de-risk pharmaceutical production by localising and streamlining supply chains.
Yuliyana Manolova, director Business Development Contract Manufacturing at Acino, explores the challenges generics manufacturing in Europe faces, and the actions pharma companies must take to better navigate the current market environment.
LLS Health's experts, Joey Glassco, MBA, Injectable Drug Delivery, and Nick DiFranco, MEM, global market segment manager, share the API solubility puzzle that the pharma industry faces and how to solve it.
Punya Abbhi, COO at Celegence, explains how the adoption of digital technologies enables companies to manage their regulatory compliance requirements in a more efficient and reliable manner.
Allen Jacques, industry thought leader at Kinaxis, shares that by using technology to improve supply chain visibility and transparency, companies can plan for volatility and identify potential disruption before it occurs,
Lisa Caralli, Science and Technology director, Pharmaceutics, Catalent, discusses the methods that formulation scientists can undertake on small quantities of API to achieve the greatest possible results to progress through drug product development.
Dr. Julia Rashba-Step, VP of R&D and Alliance Management at Phosphorex, explains how its using microfluidics to help its clients accelerate their nanoparticle fabrication and forward the development of new nanomedicines.
Mark Yeeles, VP Industrial Automation, Schneider Electric, examines five important areas pharmaceutical facilities need to be aware of to transform their operations and improve production.
Alan Ryan, owner of Technoprint, outlines some of the ways the business makes sure it stays ahead of the game when it comes to sustainability. Alan delves deeper into the topic of leaflets, packaging and sourcing products sustainability.
EPM sat with Marivi Mendizabal, vice president Quality and Regulatory, Cytiva, as she explains how government policy and regulatory trends impact the biopharma industry, and how collaborating with the government can enhance biopharma resilience.
Download this whitepaper and read through Camfil's 10 tips on the most important factors to consider when determining reliable dust collection solutions for tablet press applications.
